Sound-wave imaging for prostate cancer proton therapy
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a new imaging method that uses sound waves to check the accuracy of proton radiation therapy for prostate cancer. It aims to improve treatment precision while being non-invasive, and participants will need to tolerate a water-filled ultrasound pad on their skin during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have prostate cancer.
- The cancer must not have spread to the lymph nodes (near the prostate).
- Your weight must be under 350 lbs.
- The treatment area must be no larger than 15 cm by 15 cm (and less than 20 cm thick).
- You must be scheduled to receive proton radiation therapy (using a specific machine called ProteusONE).
- You must be comfortable with a water-filled pad and ultrasound sensors touching your skin during treatment, and you must not have any implants or hardware in that area.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a high-intensity focused ultrasound treatment can help people with localized prostate cancer while still avoiding traditional full-dose treatment for some patients. It may be an option for certain intermediate-risk cases where the cancer is confined to the prostate.
This trial tests a new, non-surgical treatment called irreversible electroporation (IRE) for men with early-stage prostate cancer that hasn't spread. It uses short electrical pulses to destroy cancer cells while sparing healthy tissue nearby.
This trial tests a stronger, more focused radiation dose to the main tumor inside the prostate using MRI guidance. It aims to improve control of intermediate-risk prostate cancer while possibly reducing side effects.
This trial studies whether a special ultrasound method (power Doppler ultrasound) can better guide where needles go during high-dose-rate radiation treatment for prostate cancer. The goal is to improve targeting during the procedure while you receive standard treatment.
This trial tests whether a precisely targeted laser procedure—guided by MRI images—can treat prostate cancer. It may help some men who have a certain type and location of tumor while aiming to avoid nearby sensitive structures.
This trial tests whether a single, image-guided radiation treatment can treat intermediate-risk prostate cancer while better protecting the urethra (the urine tube). It may help patients get effective cancer control with potentially fewer urinary side effects, depending on the results.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.